pI: 4.3467 |
Length (AA): 588 |
MW (Da): 62500 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
86 | 208 | 2mqa (A) | 17 | 140 | 20.00 | 0 | 0.04 | 0.420184 | -0.77 |
163 | 576 | 3qvc (A) | 83 | 325 | 21.00 | 0 | 1 | 0.712182 | 0.3 |
213 | 587 | 2qzx (A) | 1 | 341 | 39.00 | 0 | 1 | 1.04026 | -0.62 |
217 | 584 | 3pvk (A) | 5 | 338 | 42.00 | 0 | 1 | 1.01635 | -0.4 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_176194)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.8376 | secretory aspartyl proteinase SAP7p |
Candida albicans | CaO19.756 | secretory aspartyl proteinase SAP7p |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin II | 453 aa | 24.2% | 385 aa | Compounds | References |
Macaca fascicularis | Renin | 406 aa | 24.4% | 373 aa | Compounds | References |
Plasmodium falciparum | plasmepsin I | 452 aa | 24.9% | 373 aa | Compounds | References |
Sus scrofa | Pepsin A | 385 aa | 26.9% | 361 aa | Compounds | References |
Rattus norvegicus | Pepsinogen C | 392 aa | 22.8% | 373 aa | Compounds | References |
Callithrix jacchus | Renin | 400 aa | 25.4% | 374 aa | Compounds | References |
Macaca mulatta | Renin | 406 aa | 24.7% | 373 aa | Compounds | References |
Plasmodium falciparum | plasmepsin III | 451 aa | 22.3% | 363 aa | Compounds | References |
Penicillium janthinellum | Penicillopepsin | 323 aa | 26.4% | 348 aa | Compounds | References |
Rhizopus microsporus var. chinensis | Rhizopuspepsin | 393 aa | 24.9% | 361 aa | Compounds | References |
Bos taurus | Cathepsin D | 390 aa | 24.4% | 385 aa | Compounds | References |
Schistosoma mansoni | cathepsin D (A01 family) | 430 aa | 25.1% | 374 aa | Compounds | References |
Schistosoma mansoni | cathepsin D (A01 family) | 428 aa | 25.1% | 374 aa | Compounds | References |
Plasmodium vivax | plasmepsin IV, putative | 450 aa | 24.0% | 362 aa | Compounds | References |